Prudential Financial Inc. decreased its position in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 0.1% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 47,640 shares of the company’s stock after selling 40 shares during the period. Prudential Financial Inc. owned 0.12% of Phibro Animal Health Corporation worth $1,339,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in the stock. Mason Street Advisors LLC boosted its position in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares during the period. Louisiana State Employees Retirement System boosted its position in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock worth $211,000 after buying an additional 100 shares during the period. CAPROCK Group Inc. acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth $213,000. New York State Teachers Retirement System boosted its position in shares of Phibro Animal Health Corporation by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 7,343 shares of the company’s stock worth $215,000 after buying an additional 100 shares during the period. Finally, Campbell & CO Investment Adviser LLC acquired a new position in shares of Phibro Animal Health Corporation during the first quarter worth $228,000. Institutional investors and hedge funds own 47.64% of the company’s stock.
Phibro Animal Health Corporation (NASDAQ PAHC) traded up 0.25% during mid-day trading on Monday, reaching $39.75. 110,518 shares of the company traded hands. Phibro Animal Health Corporation has a 52-week low of $20.14 and a 52-week high of $40.25. The stock has a market capitalization of $1.58 billion, a PE ratio of 24.69 and a beta of 1.35. The firm’s 50-day moving average is $38.03 and its 200 day moving average is $32.23.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 27th. Investors of record on Wednesday, September 6th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 1.01%. The ex-dividend date of this dividend is Friday, September 1st. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 24.69%.
WARNING: “Phibro Animal Health Corporation (NASDAQ:PAHC) Shares Sold by Prudential Financial Inc.” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/14/phibro-animal-health-corporation-nasdaqpahc-shares-sold-by-prudential-financial-inc-updated-updated-updated.html.
A number of research analysts recently issued reports on the stock. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price target for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a research note on Thursday, May 11th. BidaskClub upgraded shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Finally, Piper Jaffray Companies set a $35.00 price target on shares of Phibro Animal Health Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Phibro Animal Health Corporation currently has a consensus rating of “Hold” and an average target price of $30.50.
In other Phibro Animal Health Corporation news, insider Jack Bendheim sold 48,000 shares of the firm’s stock in a transaction on Thursday, May 25th. The stock was sold at an average price of $34.67, for a total value of $1,664,160.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Bfi Co., Llc sold 16,000 shares of the firm’s stock in a transaction on Wednesday, July 5th. The shares were sold at an average price of $36.98, for a total value of $591,680.00. Following the completion of the sale, the insider now owns 28,000 shares in the company, valued at $1,035,440. The disclosure for this sale can be found here. Insiders have sold 352,000 shares of company stock worth $12,599,200 over the last 90 days. 48.09% of the stock is currently owned by company insiders.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
